Publicaciones (46) Publicaciones de JESUS MIGUEL UNDA URZAIZ

2024

  1. Consensus document on the implications of standardization of BCG supply in the management of patients with non-muscle-invasive bladder cancer

    Actas Urologicas Espanolas

  2. MetSCORE: a molecular metric to evaluate the risk of metabolic syndrome based on serum NMR metabolomics

    Cardiovascular Diabetology, Vol. 23, Núm. 1

  3. Why is it necessary to produce a BCG strain in Spain?

    Actas Urologicas Espanolas

2023

  1. A multidisciplinary consensus statement on the optimal pharmacological treatment for metastatic hormone-sensitive prostate cancer

    Actas Urologicas Espanolas, Vol. 47, Núm. 2, pp. 111-126

  2. Abiraterone in low-volume metastatic hormone-sensitive prostate cancer. Authors’ reply

    Actas Urologicas Espanolas

  3. Hormone sensitive protocol for metastatic prostate cancer, an update

    Actas Urologicas Espanolas, Vol. 47, Núm. 4, pp. 244-249

  4. Hyperthermic Mitomycin C in Intermediate-risk Non-muscle-invasive Bladder Cancer: Results of the HIVEC-1 Trial

    European urology oncology, Vol. 6, Núm. 1, pp. 58-66

  5. Identifying prognostic parameters related to surgical technique in patients treated by robotic radical prostatectomy

    Actas Urologicas Espanolas, Vol. 47, Núm. 1, pp. 47-55

  6. METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancer

    Molecular cancer, Vol. 22, Núm. 1, pp. 119

  7. Using the Synergy between HPLC-MS and MALDI-MS Imaging to Explore the Lipidomics of Clear Cell Renal Cell Carcinoma

    Analytical Chemistry, Vol. 95, Núm. 4, pp. 2285-2293

2022

  1. Non-metastatic castration-resistant prostate cancer: management recommendations

    Actas Urologicas Espanolas, Vol. 46, Núm. 4, pp. 193-213

  2. PI3K-regulated Glycine N-methyltransferase is required for the development of prostate cancer

    Oncogenesis, Vol. 11, Núm. 1

2021

  1. Clinical implications of (Pro)renin receptor (prr) expression in renal tumours

    Diagnostics, Vol. 11, Núm. 2

  2. Soluble pd-l1 is an independent prognostic factor in clear cell renal cell carcinoma

    Cancers, Vol. 13, Núm. 4, pp. 1-17

2020

  1. 1H NMR-Based Urine Metabolomics Reveals Signs of Enhanced Carbon and Nitrogen Recycling in Prostate Cancer

    Journal of Proteome Research, Vol. 19, Núm. 6, pp. 2419-2428

  2. Perspectiva histórica del tratamiento sistémico del cáncer de vejiga músculo invasivo

    Archivos espanoles de urologia, Vol. 73, Núm. 10, pp. 954-960

  3. The urinary transcriptome as a source of biomarkers for prostate cancer

    Cancers, Vol. 12, Núm. 2

2018

  1. Integrative analysis of transcriptomics and clinical data uncovers the tumor-suppressive activity of MITF in prostate cancer

    Cell Death and Disease, Vol. 9, Núm. 10

  2. Metabolic alterations in urine extracellular vesicles are associated to prostate cancer pathogenesis and progression

    Journal of Extracellular Vesicles, Vol. 7, Núm. 1

  3. PPARd elicits ligand-independent repression of trefoil factor family to limit prostate cancer growth

    Cancer Research, Vol. 78, Núm. 2, pp. 399-409